Drug Research
Parexel, Partex Partner to Accelerate Drug Discovery and Development
Parexel, a CRO providing a full range of Phase I to IV clinical development services, and Partex, a digital pharma platform, entered a strategic alliance designed to leverage artificial intelligence (AI)-powered solutions to accelerate drug discovery and development for...
Drug Research
AGC Biologics, Asahi Kasei Enter Clinical Drug Substance Agreement
AGC Biologics, a global biopharmaceutical CDMO, entered a new agreement with Asahi Kasei Pharma to produce clinical drug substance for antibody-based therapies at AGC Biologics’ Seattle manufacturing site.AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to...
Drug Research
Chiesi, Aliada Therapeutics Enter Drug Delivery Alliance
Chiesi Global Rare Diseases has entered a co-development agreement with Aliada Therapeutics, a biotechnology company developing a novel blood-brain barrier (BBB)-crossing platform technology to address challenging disease areas with high unmet need.The collaboration will focus on multiple enzyme cargoes...
Drug Research
Croda Pharma introduces new bioprocessing solutions to replace banned materials
Croda Pharma has introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need for replacing the popular, but now banned,...
Drug Research
The Rise of mRNA Technology In Parenteral Drug Manufacturing
The parenteral drug manufacturing process is anchored by the Supply Chain. The impact of COVID-19 has influenced both positively and negatively the production of contemporary parenteral drugs. Many manufacturers have structured their systems around the lean Just-In-Time (JIT) production...
Drug Research
Lonza Launches Nebula Absorbance Reader for Streamlined Endotoxin and Pyrogen Testing
Lonza has launched the Nebula® Absorbance Reader, a new absorbance microplate reader which joins the company’s portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.
Pharmaceutical quality control (QC) laboratories worldwide rely on the traditional absorbance-based Limulus amebocyte lysate (LAL) and Tachypleus amebocyte...
Drug Research
Emerging Markets Drive Small Molecule API Market Expansion
As per insights, a significant increase in the small molecule active pharmaceutical ingredient (API) market has been projected, estimating it to be valued at approximately $284.7 billion by 2032, compared to $162.8 billion in 2022. A compound annual growth...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read